Alprazolam: Uses, Dosage, Side Effects & Brands | MedexInfo

Alprazolam

Rx Only

Generic:Alprazolam

Therapeutic ClassBenzodiazepine

Common Dose0.25–0.5 mg 2–3 times daily

Max / 24h4 mg

PregnancyCategory D

Indications ▼

Generalized anxiety disorder (GAD)

Panic disorder with or without agoraphobia

Anxiety associated with depression

Mechanism & Pharmacokinetics ▼

Mechanism: Enhances the effect of the inhibitory neurotransmitter GABA by binding to the benzodiazepine site on GABA-A receptors, leading to CNS depression and anxiolytic, sedative, muscle relaxant effects.

Pharmacokinetics: Rapid oral absorption; peak plasma 1–2 hr; metabolized primarily in liver by CYP3A4; excreted in urine; half-life ~12–15 hr.

Dosage & Administration ▼

Patient Category	Recommended Dose	Max / 24h
Adults	0.25–0.5 mg orally 2–3 times daily; titrate as needed	4 mg
Elderly / Debilitated	Start 0.25 mg 1–2 times daily	2 mg
Children (≥6 yr)	Not routinely recommended; pediatric use under specialist guidance	Varies

Note: Tablets may be taken with or without water; avoid abrupt discontinuation after prolonged use.

Side Effects ▼

Common: Drowsiness, sedation, fatigue, dizziness

Occasional: Dry mouth, blurred vision, GI upset

Rare: Paradoxical reactions (agitation, aggression), dependence, withdrawal symptoms, respiratory depression

Contraindications ▼

Hypersensitivity to benzodiazepines

Acute narrow-angle glaucoma

Severe respiratory insufficiency

Pregnancy (especially first trimester) unless clearly needed

Drug Interaction ▼

CYP3A4 inhibitors (ketoconazole, itraconazole, ritonavir) increase plasma levels

Alcohol and other CNS depressants: additive sedation

Other benzodiazepines: additive CNS depression

Pregnancy & Lactation ▼

Pregnancy Category D: risk of congenital malformations; use only if benefits outweigh risks

Excreted in breast milk; monitor infant for sedation

Clinical / Research Summary ▼

Anxiolytic Efficacy: Rapid reduction of anxiety symptoms in GAD and panic disorders; onset 30–60 min.

Panic Disorder Management: Decreases frequency and severity of panic attacks; improves quality of life.

Pharmacokinetic Advantage: Short half-life reduces morning sedation risk; suitable for PRN dosing in panic attacks.

Safety Profile: Generally well-tolerated; risk of dependence with prolonged use; monitor for CNS depression.

Current Research Focus: Long-term safety, tapering strategies, combination therapy with SSRIs, and cognitive-behavioral therapy adjuncts.

Storage & Handling ▼

Store at 20–25°C; protect from moisture & light

Keep out of reach of children

Patient Counseling Points ▼

Take tablets with or without water, preferably at the same time each day.

Avoid alcohol and other CNS depressants.

Do not stop abruptly; taper dose under medical supervision.

Report excessive sedation, confusion, or paradoxical reactions.

Store safely; risk of misuse or dependence.

Brand Names (Bangladesh & Global) ▼

Bangladesh (Local Brands):

Zolium Xanax

Global / International Brands:

Xanax Alprax

Medical Disclaimer: This clinical summary is for informational purposes only. Always follow guidance from a qualified healthcare professional for dosage, interactions, and use.

Reference Hubs:

• Drug Class: Benzodiazepines • Conditions: Anxiety & Panic Disorders • Pathway: GABA-A Receptor Modulation • Clinical Evidence & Trials